Inverse association between free insulin-like growth factor-1 and isovolumic relaxation in arterial systemic hypertension

Hypertension

Volumn 38, Issue 4, 2001, Pages 840-845

  Galderisi, Maurizio ^a   Vitale, Giovanni ^a   Lupoli, Giovanni ^a   Barbieri, Michelangela ^a   Varricchio, Gina ^a   Carella, Carlo ^a   De Divitiis, Oreste ^a   Paolisso, Giuseppe ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Diastole; Echocardiography; Hypertension, arterial; Insulin growth factor; Relaxation

Indexed keywords

SOMATOMEDIN C;

ADULT; ARTERY DILATATION; ARTERY RESISTANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE; HORMONE SYNTHESIS; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0035724110     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy1001.091776     Document Type: Article

References (59)

1. Abnormal left ventricular filling: An early finding in mild to moderate systemic hypertension
2. Is insulin action a determinant of left ventricular relaxation in uncomplicated essential hypertension?
3. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome
4. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension
5. Insulin-like growth factor I in essential hypertension
6. Isolation and partial characterization of the IGF-like peptides from Cohn fraction IV of human plasma
7. Regulation of insulin-like growth factor I gene expression by growth hormone
8. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action
9. Impairment of myocyte contractility following coronary artery narrowing is associated with activation of the myocyte IGF-1 autocrine system, enhanced expression of late growth related genes, DNA synthesis, and myocyte nuclear mitotic division in rats
10. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat: A combined in vivo and in vitro evaluation
11. Mortality in acromegaly
12. Epidemiology and long-term survival in acromegaly: A study of 166 cases diagnosed between 1955 and 1984
13. Acromegaly and cardiovascular disorders: A prospective study
14. Insulin-like growth factor-1 induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes
15. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: Effect of short- and long-term weight recuperation
16. Recommendation regarding quantitation in M-mode echocardiographic measurements
17. Echocardiographic determination of left ventricular mass: Anatomic validation of the method
18. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart study
19. Evaluation of left ventricular diastolic function
20. Assessment of diastolic function of the heart: Background and current applications of Doppler echocardiography, part II: Clinical studies
21. Cardiac involvement in acromegaly: Specific myocardiopathy or consequence of systematic hypertension?
22. Insulin-like growth factor-1 and cardiac mass in essential hypertension: Comparative effects of captopril, lisinopril and quinapril
23. Insulin-like growth factor binding proteins in arterial hypertension: Relationship to left ventricular hypertrophy
24. Is the tissue availability of circulating insulin-like growth factor involved in organ damage and glucose regulation in hypertension?
25. Diastolic properties of left ventricle
26. Relation of left ventricular diastolic properties to systolic function in arterial hypertension
27. Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function
28. Determinants of Doppler indices of diastolic function in normal subjects (the Framingham Heart StUdy)
29. Preload dependence of Doppler-derived indexes of left ventricular diastolic fuction in humans
30. Impact of ambulatory blood pressure on left ventricular diastolic dysfunction in uncomplicated arterial systemic hypertension
31. Cardiac hypertrophy: The consequences for diastole
32. Diastolic failure: Pathophysiology and therapeutic implications
33. Left ventricular filling pattern in uncomplicated obesity
34. Echocardiographic evidence for a direct effect of GH/IGF-1 hypersecretion on cardiac mass and function in young acromegalics
35. Evidence for biventricular involvement in acromegaly: A Doppler echocardiographic study
36. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly
37. Extensive personal experience: Acromegaly
38. Impaired left ventricular diastolic function in acromegaly: An echocardiographic study
39. Identification and characterization of insulin-like growth factor receptors on adult rat cardiac myocytes: Linkage to inositol 1,4,5-trisphosphate formation
40. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology
41. Growth factors mediate intracellular signaling in vascular smooth muscle cells through protein kinase C-linked pathways
42. 2+ through a wortmannin-sensitive pathway: Studies in rat and ferret isolated muscles
43. The effect of insulin-like growth factor-1 on adult rat cardiac contractility
44. Altered inotropic response to insulin-like growth factor I in diabetic rat heart: Influence of intracellular Ca and nitric oxide
45. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
46. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy
47. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilatation, wall stress and cardiac hypertrophy
48. Influence of age on contractile response to insulin-like growth factor 1 in ventricular myocytes from spontaneously hypertensive rats
49. Increased expression of low-affinity insulin receptor isoform and insulin-like growth factor-1 hybrid receptors in term placenta from insulin-resistant women with gestational hypertension
50. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension
51. Nitric oxide and cardiac function
52. Cellular ionic alterations with age: Relation to hypertension and diabetes
53. Altered ionic effects of insulin in hypertension: Role of basal ion levels in determining cellular responsiveness
54. Regulation of cardiac muscle function in the hypertensive heart
55. Myocardial infarction and the myocyte IGF-1 autocrine system
56. Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart
57. Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice
58. Insulin-like growth factor-1 decreases sympathetic nerve activity: The effect is modulated by glycemic status